Avanos Medical (AVNS) Finished Goods (2016 - 2024)
Historic Finished Goods for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to $87.9 million.
- Avanos Medical's Finished Goods rose 80.28% to $87.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $87.9 million, marking a year-over-year increase of 80.28%. This contributed to the annual value of $88.5 million for FY2023, which is 2679.08% up from last year.
- Per Avanos Medical's latest filing, its Finished Goods stood at $87.9 million for Q3 2024, which was up 80.28% from $86.2 million recorded in Q2 2024.
- Avanos Medical's 5-year Finished Goods high stood at $103.4 million for Q1 2023, and its period low was $69.8 million during Q4 2022.
- In the last 5 years, Avanos Medical's Finished Goods had a median value of $86.2 million in 2024 and averaged $84.6 million.
- In the last 5 years, Avanos Medical's Finished Goods plummeted by 2079.65% in 2021 and then skyrocketed by 2957.39% in 2023.
- Quarter analysis of 5 years shows Avanos Medical's Finished Goods stood at $90.4 million in 2020, then dropped by 20.8% to $71.6 million in 2021, then fell by 2.51% to $69.8 million in 2022, then rose by 26.79% to $88.5 million in 2023, then decreased by 0.68% to $87.9 million in 2024.
- Its Finished Goods was $87.9 million in Q3 2024, compared to $86.2 million in Q2 2024 and $84.0 million in Q1 2024.